iCo Therapeutics (OTCMKTS:ICOTF) Shares Pass Below 200 Day Moving Average of $0.06

Shares of iCo Therapeutics Inc (OTCMKTS:ICOTF) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.06 and traded as low as $0.11. iCo Therapeutics shares last traded at $0.11, with a volume of 5,000 shares.

The stock’s 50-day moving average is $0.07 and its 200-day moving average is $0.06.

iCo Therapeutics Company Profile (OTCMKTS:ICOTF)

iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.

Read More: How to Track your Portfolio in Google Finance

Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit